“Emerging data from this confirmatory study have highlighted a safety profile that is unfavorable compared to that previously observed in clinical evaluation.” — Christelle Huguet, PhD, Ipsen

“Second-line therapy should not be dismissed outright in platinum-refractory or early-relapsing disease. It remains a relevant part of comprehensive care.” — Tingting Tan, MD, PhD, City of Hope

“Extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage.” — Angelo D’Alessandro, PhD, University of Colorado Anschutz

“The SunRISe-2 trial was stopped in advance for futility based on week-18 overall response rate assessment and the totality of the efficacy data. However, the CR rates in both arms are compelling.” — Andrea Necchi, MD, ASCO GU Symposium 2026

“At 10 years, BCF was 38.0% for HDR compared with 10.4% for SBRT.” — Udovicich et al., JAMA Network Open, February 2026

“It gives clinicians objective clinical evidence guidance as to the risks and benefits of napping and catching up on sleep during weekends.” — Kaushik Govindaraju, DO, Medical Offices of Manhattan